Live Transport for Cell and Gene Therapy Products with Cryo Medical Logistics
- Cryo Medical Logistics
- 3 days ago
- 4 min read
Contact us: 💬
WhatsApp: +44 7585 610211 (typically responds within 1 hour)
📞 +44 20 8150 0059 Email: contact@cryomedicallogistics.com
Cell and gene therapies don't tolerate the kind of handling that ordinary medical cargo can. A live cell line, an autologous cell product, or a gene therapy vector can lose viability from a temperature swing, a delay, or a moment spent unsupervised — and unlike a physical product, that loss usually can't be remade on short notice. It has to be manufactured, or collected from the patient, again.
That's why we treat cell and gene therapy transport as a distinct discipline from general pharmaceutical or biological logistics, built around continuous physiological control and constant custody.
TL;DR
We provide live transport for cell and gene therapy products, including live cell lines and other advanced therapy materials that cannot be frozen.
Samples travel in portable CO2 incubator chambers that maintain physiological temperature, gas concentration, and humidity throughout transit.
Every shipment is hand-carried by a trained courier — never checked as cargo, never left unsupervised at any point in the journey.
We coordinate directly with sending and receiving facilities to plan around the product's specific viability window.
Available globally, subject to route feasibility for time-critical shipments.
Why Cell and Gene Therapy Transport Is a Distinct Category
Cell and gene therapies are often manufactured in one location and administered in another — sometimes in a different country. Between manufacture and administration, the product typically has a defined, and often short, window in which it remains viable. Autologous products carry additional weight: they're derived from an individual patient, which means a failed shipment isn't just a logistics cost, it's a lost treatment cycle for that patient.
General pharmaceutical cold-chain logistics isn't built for this. It's designed around stable, replaceable products moving through standard distribution networks. Live cell and gene therapy transport requires the opposite: continuous environmental control, an unbroken chain of custody, and a courier trained specifically to manage a live biological product rather than a packaged one.
What We Transport
Live cell lines and cell-based therapy products
Autologous and allogeneic cell therapy materials
Gene therapy vectors and related advanced therapy products requiring physiological transport conditions
Other live biological materials that cannot be cryopreserved without loss of viability
How It Works
Pre-shipment coordination. We work with the manufacturing site and receiving facility in advance to confirm the product's viability window and any handling-specific requirements.
Loading into a controlled chamber. The product is placed into a portable CO2 incubator chamber, maintained at conditions matched to its physiological requirements.
Continuous hand-carry custody. A trained courier accompanies the product for the entire journey — it is never checked as cargo and never left in an unsupervised holding area.
Real-time environmental monitoring. Temperature and gas conditions are tracked throughout transit, with the courier positioned to respond immediately to any deviation.
Direct facility hand-off. The product is delivered directly to receiving facility staff, maintaining chain of custody to the final point of administration.
The Technology Behind the Chamber
Maintains temperature between ambient room temperature and 37°C, adjustable in 0.1°C increments
Holds a stable temperature for up to 24 hours under typical ambient conditions
Compatible with a range of sample formats, including multiwell plates, T-flasks, and chip-based formats
Continuous environmental data logging throughout transit, providing a full record of conditions from collection to delivery
Packed and carried to meet international biological transport standards and relevant IATA air packing requirements
Built on Protocols Facilities Can Rely On
ISO 9001:2015 compliant quality management across our operations
FCA-regulated insurance covering biological material in transit
Hand-carry-only protocol, maintaining unbroken chain of custody from collection to delivery
Do Not X-Ray protocol coordination with airline and airport security to protect product integrity
FDA-registered storage where applicable for US-based handling, alongside coordination with the relevant regulatory framework in the receiving country
Contact us: 💬
WhatsApp: +44 7585 610211 (typically responds within 1 hour)
📞 +44 20 8150 0059 Email: contact@cryomedicallogistics.com
Frequently Asked Questions
Can live cell and gene therapy products be shipped without freezing? Yes. Many cell and gene therapy products need to remain at physiological temperature rather than being frozen, and can be transported using a portable CO2 incubator that maintains stable temperature and gas conditions throughout the journey.
How is chain of custody maintained during transport? Every product is hand-carried by a trained courier from collection to delivery. It is never checked as cargo and never left unsupervised at any point in the journey.
Can you coordinate transport for autologous cell therapy products? Yes. We coordinate directly with the manufacturing site and receiving facility in advance to plan transport around the specific viability window and handling requirements of an autologous product.
Is this service available for international shipments? Yes, subject to route feasibility. Because these products are time-critical, flight routing and connection times are assessed carefully before a booking is confirmed.
What happens if there's a delay during transport? The accompanying courier monitors environmental conditions continuously and is positioned to respond immediately to any deviation, with the receiving facility kept informed throughout.
Comments